CAUTI’s next top model – Model dependent Klebsiella biofilm inhibition by bacteriophages and antimicrobials

Tacconelli, 2018, ’Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis, Lancet Infect Dis, 18, 318, 10.1016/S1473-3099(17)30753-3 Podschun, 1998, ’Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors, Clin Microbiol Rev, 11, 589, 10.1128/CMR.11.4.589 Caneiras, 2019, Community- and hospital-acquired Klebsiella pneumoniae urinary tract infections in Portugal: virulence and antibiotic resistance, Microorganisms, 7, 138, 10.3390/microorganisms7050138 Langarizadeh, 2011, ’Prevalence of multi-drug resistant (MDR) Klebsiella pneumoniae among children and adults with urinary tract infection referred to tabriz teaching hospitals, Journal of animal physiology and development, 4, 9 Sanchez, 2013, ’Klebsiella pneumoniae antimicrobial drug resistance, United States, 1998-2010’, Emerg Infect Dis, 19, 133, 10.3201/eid1901.120310 Elemam, 2009, ’Infection with panresistant Klebsiella pneumoniae: a report of 2 cases and a brief review of the literature, Clin Infect Dis, 49, 271, 10.1086/600042 Lina, 2007, ’Multiple-antibiotic resistance mediated by plasmids and integrons in uropathogenic Escherichia coli and Klebsiella pneumoniae, Bangladesh J Microbiol, 24, 19, 10.3329/bjm.v24i1.1231 Ramirez, 2019, Small Klebsiella pneumoniae plasmids: neglected contributors to antibiotic resistance, Front Microbiol, 10, 2182, 10.3389/fmicb.2019.02182 Navon-Venezia, 2017, ’Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance, FEMS Microbiol Rev, 41, 252, 10.1093/femsre/fux013 Ben-David, 2012, ’Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections, Clin Microbiol Infect, 18, 54, 10.1111/j.1469-0691.2011.03478.x Zahller, 2002, ’Transmission electron microscopic study of antibiotic action on Klebsiella pneumoniae biofilm, Antimicrob Agents Chemother, 46, 2679, 10.1128/AAC.46.8.2679-2683.2002 Singla, 2014, ’Artificial Klebsiella pneumoniae biofilm model mimicking in vivo system: altered morphological characteristics and antibiotic resistance, J Antibiot, 67, 305, 10.1038/ja.2013.139 Anderl, 2000, Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin, Antimicrob Agents Chemother, 44, 1818, 10.1128/AAC.44.7.1818-1824.2000 Van Laar, 2015, ’Sublethal concentrations of carbapenems alter cell morphology and genomic expression of Klebsiella pneumoniae biofilms, Antimicrob Agents Chemother, 59, 1707, 10.1128/AAC.04581-14 Hennequin, 2012, ’Antibiotic resistance and plasmid transfer capacity in biofilm formed with a CTX-M-15-producing Klebsiella pneumoniae isolate, J Antimicrob Chemother, 67, 2123, 10.1093/jac/dks169 Yang, 2008, ’Biofilm-forming Klebsiella pneumoniae strains have greater likelihood of producing extended-spectrum β-lactamases, J Hosp Infect, 68, 369, 10.1016/j.jhin.2008.02.001 Hidron, 2008, ’Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2006–2007, Infect Contr Hosp Epidemiol, 29, 996, 10.1086/591861 Wazait, 2003, ’Catheter-associated urinary tract infections: prevalence of uropathogens and pattern of antimicrobial resistance in a UK hospital (1996-2001), BJU Int, 91, 806, 10.1046/j.1464-410X.2003.04239.x Sabir, 2017, ’Bacterial biofilm-based catheter-associated urinary tract infections: causative pathogens and antibiotic resistance, Am J Infect Contr, 45, 1101, 10.1016/j.ajic.2017.05.009 Gill, 2010, ’Phage choice, isolation, and preparation for phage therapy, Curr Pharmaceut Biotechnol, 11, 2, 10.2174/138920110790725311 d’Herelle, 1931, ’Bacteriophage as a treatment in acute medical and surgical infections, Bull N Y Acad Med, 7, 329 Gorski, 2005, The potential role of endogenous bacteriophages in controlling invading pathogens, Cell Mol Life Sci, 62, 511, 10.1007/s00018-004-4403-6 Parisien, 2008, ’Novel alternatives to antibiotics: bacteriophages, bacterial cell wall hydrolases, and antimicrobial peptides, J Appl Microbiol, 104, 1 Donlan, 2001, ’Biofilms and device-associated infections, Emerg Infect Dis, 7, 277, 10.3201/eid0702.010226 Hughes, 1998, ’Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase, Microbiology, 144, 3039, 10.1099/00221287-144-11-3039 Liao, 2012, ’Bacteriophages are synergistic with bacterial interference for the prevention of Pseudomonas aeruginosa biofilm formation on urinary catheters, J Appl Microbiol, 113, 1530, 10.1111/j.1365-2672.2012.05432.x Melo, 2016, ’Development of a phage cocktail to control Proteus mirabilis catheter-associated urinary tract infections, Front Microbiol, 7, 1024, 10.3389/fmicb.2016.01024 Lehman, 2015, ’Bacteriophage-mediated control of a two-species biofilm formed by microorganisms causing catheter-associated urinary tract infections in an in vitro urinary catheter model, Antimicrob Agents Chemother, 59, 1127, 10.1128/AAC.03786-14 Carson, 2010, The use of lytic bacteriophages in the prevention and eradication of biofilms of Proteus mirabilis and Escherichia coli, FEMS Immunol Med Microbiol, 59, 447, 10.1111/j.1574-695X.2010.00696.x Ujmajuridze, 2018, ’Adapted bacteriophages for treating urinary tract infections, Front Microbiol, 9, 1832, 10.3389/fmicb.2018.01832 Vuotto, 2017, ’Biofilm formation and antibiotic resistance in Klebsiella pneumoniae urinary strains, J Appl Microbiol, 123, 1003, 10.1111/jam.13533 Edwards, 1952, ’Capsule types of Klebsiella, J Infect Dis, 91, 92, 10.1093/infdis/91.1.92 Orskov, 1955, ’Serological investigations in the Klebsiella group. I. New capsule types, Acta Pathol Microbiol Scand, 36, 449, 10.1111/j.1699-0463.1955.tb04640.x Whitfield, 2006, ’Biosynthesis and assembly of capsular polysaccharides in Escherichia coli, Annu Rev Biochem, 75, 39, 10.1146/annurev.biochem.75.103004.142545 Nobrega, 2018, ’Targeting mechanisms of tailed bacteriophages, Nat Rev Microbiol, 16, 760, 10.1038/s41579-018-0070-8 Townsend, 2020, ’Isolation and chacterisation of Klebsiella phages for phage therapy’, bioRxiv Elbing, 2002, ’Media preparation and bacteriological tools Brooks, 1997, ’A simple artificial urine for the growth of urinary pathogens, Lett Appl Microbiol, 24, 203, 10.1046/j.1472-765X.1997.00378.x Storms, 2020, The virulence index: a metric for quantitative analysis of phage virulence, PHAGE, 1, 27, 10.1089/phage.2019.0001 Kirchner, 2012, ’Use of artificial sputum medium to test antibiotic efficacy against Pseudomonas aeruginosa in conditions more relevant to the cystic fibrosis lung, JoVE, 10.3791/3857 Chaudhry, 2017, ’Synergy and order effects of antibiotics and phages in killing Pseudomonas aeruginosa biofilms, PloS One, 12, 10.1371/journal.pone.0168615 2018, Urinary tract infection (catheter-associated): antimicrobial prescribing Hoogerheide, 1939, ’Studies on capsule formation: I. The conditions under which (Friedländer’s Bacterium) Forms Capsules, J Bacteriol, 38, 367, 10.1128/JB.38.4.367-389.1939 Hoogerheide, 1940, ’Studies on Capsule Formation: II. The Influence of Electrolytes on Capsule Formation by Klebsiella pneumoniae’, J Bacteriol, 39, 649, 10.1128/JB.39.6.649-658.1940 Ratner, 2015, ’I can see CRISPR now, even when phage are gone: a view on alternative CRISPR-Cas functions from the prokaryotic envelope, Curr Opin Infect Dis, 28, 267, 10.1097/QCO.0000000000000154 Huang, 2012, ’Role of the small RNA RyhB in the Fur regulon in mediating the capsular polysaccharide biosynthesis and iron acquisition systems in Klebsiella pneumoniae, BMC Microbiol, 12, 148, 10.1186/1471-2180-12-148 Stewart, 1992, ’Physiological studies of chloramine resistance developed by Klebsiella pneumoniae under low-nutrient growth conditions, Appl Environ Microbiol, 58, 2918, 10.1128/AEM.58.9.2918-2927.1992 Cano, 2015, ’Klebsiella pneumoniae survives within macrophages by avoiding delivery to lysosomes, Cell Microbiol, 17, 1537, 10.1111/cmi.12466 Kutateladze, 2010, ’Bacteriophages as potential new therapeutics to replace or supplement antibiotics, Trends Biotechnol, 28, 591, 10.1016/j.tibtech.2010.08.001 Wu, 2019, ’A Novel Polysaccharide Depolymerase Encoded by the Phage SH-KP152226 Confers Specific Activity Against Multidrug-Resistant via Biofilm Degradation, Front Microbiol, 10, 2768, 10.3389/fmicb.2019.02768 Geredew Kifelew, 2019, Mini-review: efficacy of lytic bacteriophages on multispecies biofilms, Biofouling, 35, 472, 10.1080/08927014.2019.1613525 Verma, 2010, ’Structural changes induced by a lytic bacteriophage make ciprofloxacin effective against older biofilm of Klebsiella pneumoniae, Biofouling, 26, 729, 10.1080/08927014.2010.511196 Hamilton-Miller, 1965, ’Modes of resistance to benzylpenicillin and ampicillin in twelve Klebsiella strains, J Gen Microbiol, 41, 175, 10.1099/00221287-41-2-175 Tait, 2002, The efficacy of bacteriophage as a method of biofilm eradication, Biofouling, 18, 305, 10.1080/0892701021000034418 Bansal, 2014, ’Depolymerase improves gentamicin efficacy during Klebsiella pneumoniae induced murine infection, BMC Infect Dis, 14, 456, 10.1186/1471-2334-14-456 Dunne, 1990, ’Effects of subinhibitory concentrations of vancomycin or cefamandole on biofilm production by coagulase-negative staphylococci, Antimicrob Agents Chemother, 34, 390, 10.1128/AAC.34.3.390 Milo, 2017, ’Prevention of encrustation and blockage of urinary catheters by Proteus mirabilis via pH-triggered release of bacteriophage, J Mater Chem B, 5, 5403, 10.1039/C7TB01302G Nzakizwanayo, 2016, ’Bacteriophage can prevent encrustation and blockage of urinary catheters by Proteus mirabilis, Antimicrob Agents Chemother, 60, 1530, 10.1128/AAC.02685-15 Dedrick, 2019, ’Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus, Nat Med, 25, 730, 10.1038/s41591-019-0437-z Ryan, 2011, ’Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy, J Pharm Pharmacol, 63, 1253, 10.1111/j.2042-7158.2011.01324.x Jamala, 2015, ’Inhibition of clinical multi-drug resistant Klebsiella pneumoniae biofilm by Siphoviridae bacteriophage Z, Sci Lett, 3, 122 Bedi, 2009, ’Amoxicillin and specific bacteriophage can be used together for eradication of biofilm of Klebsiella pneumoniae B5055, World J Microbiol Biotechnol, 25, 1145, 10.1007/s11274-009-9991-8 AlBany, 2019, ’Phage Therapy Against Biofilm of Multidrug-Resistant Klebsiella Pneumoniae Isolated from Zakho Hospital Samples, Polytechnic Journal, 9, 17, 10.25156/ptj.v9n1y2019.pp17-22 Majkowska-Skrobek, 2016, ’Capsule-targeting depolymerase, derived from Klebsiella KP36 phage, as a tool for the development of anti-virulent strategy, Viruses, 8, 324, 10.3390/v8120324 March, 2013, ’Role of bacterial surface structures on the interaction of Klebsiella pneumoniae with phagocytes, PloS One, 8, 10.1371/journal.pone.0056847